Aurélie Auguste
Veracyte (United States)(US)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Genetic factors in colorectal cancer, DNA Repair Mechanisms, Cancer Immunotherapy and Biomarkers, PARP inhibition in cancer therapy
Most-Cited Works
- → SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas(2015)357 cited
- → The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges(2015)210 cited
- → Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas(2018)209 cited
- → FOXL2: a central transcription factor of the ovary(2013)180 cited
- → Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)(2016)171 cited
- → WNT4 and RSPO1 together are required for cell proliferation in the early mouse gonad(2012)114 cited
- → CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary(2019)110 cited
- → The transcription factor FOXL2 mobilizes estrogen signaling to maintain the identity of ovarian granulosa cells(2014)106 cited
- → A Hot-spot of In-frame Duplications Activates the Oncoprotein AKT1 in Juvenile Granulosa Cell Tumors(2015)89 cited
- → Molecular analyses of juvenile granulosa cell tumors bearingAKT1mutations provide insights into tumor biology and therapeutic leads(2015)64 cited